Anges Québec, Desjardins invest $2.75 mln in Handyem

Anges Québec, Anges Québec Capital Fund and Desjardins Capital de risque have invested in a $2.75 million follow-on financing of medical device company Handyem Inc. Led by technology entrepreneur Jean-François Grenon, 23 members of Anges Québec contributed to the round. Investment proceeds will support the marketing of the company's portable flow cytometer, which was designed for life sciences researchers to measure and analyze biological samples. Founded in 2010, the Québec City-based Handyem raised $1.7 million in initial financing in January 2013.

9 December 2014•4 mins read
Feature image
LinkedInXEmail
LinkedInXEmail